Secretory phospholipases A2 activate selective functions in human eosinophils

Journal of Immunology

Volumn 170, Issue 6, 2003, Pages 3279-3288

  Triggiani, Massimo ^a   Granata, Francescopaolo ^a   Balestrieri, Barbara ^a   Petraroli, Angelica ^a   Scalia, Giulia ^b   Del Vecchio, Luigi ^b   Marone, Gianni ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CARDARELLI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 BROMOPHENACYL BROMIDE; ARACHIDONIC ACID; BETA GLUCURONIDASE; CD69 ANTIGEN; HERMES ANTIGEN; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE C4; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHOLIPASE A2; THROMBOCYTE ACTIVATING FACTOR; GROUP II SECRETORY PHOSPHOLIPASE A2; INTERLEUKIN 5; LEUKOCYTE ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOLIPASE A; RECOMBINANT PROTEIN; SNAKE VENOM; SUPEROXIDE; T LYMPHOCYTE ANTIGEN;

AIRWAY; ARTICLE; ASTHMA; CELL FUNCTION; CELL ISOLATION; CELL STIMULATION; CHRONIC INFLAMMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME RELEASE; ENZYME STRUCTURE; EOSINOPHIL; HUMAN; HUMAN CELL; HYPEREOSINOPHILIA; MEDIATOR RELEASE; PRIORITY JOURNAL; BIOSYNTHESIS; ENZYMOLOGY; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; SECRETION; SYNOVIUM;

ANTIGENS, CD; ANTIGENS, CD44; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; COBRA VENOMS; ENZYME ACTIVATION; EOSINOPHILS; GLUCURONIDASE; HUMANS; INTERLEUKIN-5; INTERLEUKIN-6; INTERLEUKIN-8; LEUKOTRIENE C4; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOLIPASES A; PLATELET ACTIVATING FACTOR; RECOMBINANT PROTEINS; SUPEROXIDES; SYNOVIAL MEMBRANE;

EID: 0037443563     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.6.3279     Document Type: Article

References (60)

1. 2. J. Biol. Chem. 269:13057.
2. 2s: comparison of arachidonoyl-selective and -nonselective enzymes. FASEB J. 7:339.
3. 2 enzymes: classification and characterization. Biochim. Biophys. Acta 1488:1.
4. 2 in human acute pancreatitis. Scand. J. Gastroenterol. 15:633.
5. 2 levels: correlation with the hemodynamic and pulmonary changes in Gram-negative septic shock. J. Lab. Clin. Med. 104:873.
6. 2, cytokines and eicosanoids in patients with burns. Burns 21:422.
7. 2 in the pathobiology of disease. Lab. Invest. 55:391.
8. 2 from synovial fluid in rheumatoid arthritis. J. Biochem. 100:1297.
9. 2 from human synovial fluid in rheumatoid arthritis. J. Biochem. 105:395.
10. 2 present in rheumatoid arthritic synovial fluid. J. Biol. Chem. 264:5335.
11. Chilton, F. H., F. J. Averill, W. C. Hubbard, A. N. Fonteh, M. Triggiani, and M. C. Liu. 1996. Antigen-induced generation of lyso-phospholipids in human airways. J. Exp. Med. 183:2235.
12. 2 and arachidonate increase in broncboalveolar lavage fluid after inhaled antigen challenge in asthmatics. Am. J. Respir. Crit. Care Med. 155:421.
13. 2 from human nasal lavage. Am. J. Respir. Cell Mol. Biol. 11:108.
14. 2 into nasal fluids after allergenic challenge: possible role in the regulation of platelet activating factor release. J. Allergy Clin. Immunol. 94:109.
15. 2 plays a role in arachidonic acid release and eicosanoid biosynthesis by mast cells. J. Immunol. 152:5438.
16. 2 via its specific binding site. FEBS Lett. 303:217.
17. 2 in nerve growth factor-stimulated rat serosal mast cells is facilitated by interaction with fibroblasts and mediated by a mechanism independent of their enzymatic functions. J. Immunol. 161:5008.
18. 2 induce β-glucuronidase release and IL-6 production from human lung macrophages. J. Immunol. 164:4908.
19. 2 in murine bone marrow-derived mast cells. J. Immunol. 165:2773.
20. 2 isotypes. J. Immunol. 167:4161.
21. Marone, G. 2000. Human Eosinophils. Karger, Basel.
22. Triggiani, M., D. W. Goldman, and F. H. Chilton. 1991. Biological effects of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in the human neutrophil. Biochim. Biophys. Acta 1084:41.
23. Patella, V., I. Marino, B. Lamparter, E. Arbustini, M. Adt, and G. Marone. 1995. Human heart mast cells: isolation, purification, ultrastructure, and immunologic characterization. J. Immunol. 154:2855.
24. Pick, E., and D. Mizel. 1981. Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J. Immunol. Methods 46:211.
25. Snedecor, G. W. 1980. Statistical Methods. Iowa State University Press, Ames.
26. Broide, D. H., M. M. Paine, and G. S. Firestein. 1992. Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J. Clin. Invest. 90:1414.
27. Harold, Q., J. Barkans, Q. Meng, S. Ying, J. S. Abrams, A. B. Kay, and R. Moqbel. 1992. Human eosinophils synthesize and secrete interleukin-6, in vitro. Blood 80:1496.
28. Yousefi, S., S. Hemmann, M. Weber, C. Holzer, K. Hartung, K. Blaser, and H. U. Simon. 1995. IL-8 is expressed by human peripheral blood eosinophils: evidence for increased secretion in asthma. J. Immunol. 154:5481.
29. Matsumoto, K., J. Appiah-Pippim, R. P. Schleimer, C. A. Bickel, L. A. Beck, and B. S. Bochner. 1998. CD44 and CD69 represent different types of cell-surface activation markers for human eosinophils. Am. J. Respir. Cell Mol. Biol. 18:860.
30. 2. Inflamm. Res. 49:177.
31. Schauer, U., C. Leinhaas, R. Jager, and C. H. Rieger. 1991. Enhanced superoxide generation by eosinophils from asthmatic children. Int. Arch. Allergy Appl. Immunol. 96:317.
32. 2 inhibitor. J. Pharmacol. Exp. Ther. 278:252.
33. 4, increase the release of mucus from human airways in vitro. Am. Rev. Respir. Dis. 126:449.
34. 4 and to methacholine in patients with as asthma and normal controls. N. Engl. J. Med. 315:480.
35. Triggiani, M., C. Calabrese, F. Granata, M. Gentile, and G. Marone. 2000. Metabolism of lipid mediators in human eosinophils. Chem. Immunol. 76:77.
36. Triggiani, M., R. P. Schleimer, J. A. Warner, and F. H. Chilton. 1991. Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet-activating factor by human inflammatory cells. J. Immunol. 147:660.
37. Chilton, F. H., J. M. Ellis, S. C. Olson, and R. L. Wykle. 1984. 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine: a common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes. J. Biol. Chem. 259:12014.
38. Brash, A. R. 2001. Arachidonic acid as a bioactive molecule. J. Clin. Invest. 107:1339.
39. 2 stimulates inducible nitric oxide synthase expression via ERK and NF-κB in macrophages. Eur. J. Immunol. 31:2709.
40. 2s in regulating arachidonic acid release and prostaglandin generation: implications of cyclooxygenase-2 induction and phospholipid scramblase-mediated cellular membrane perturbation. J. Biol. Chem. 274:31435.
41. 2 but not the group IB, IIA, and V enzymes efficiently release arachidonic acid from adherent mammalian cells. J. Biol. Chem. 275:3179.
42. 2 induce cytokine release from blood and synovial fluid monocytes. Eur. J. Immunol. 32:67.
43. Rennard, S. I., G. Basset, D. Lecossier, K. M. O'Donnell, P. Pinkston, P. G. Martin, and R. G. Crystal. 1986. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J. Appl. Physiol. 60:532.
44. 2. Blood 91:3037.
45. Nakajima, H., G. J. Gleich. and H. Kita. 1996. Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils. J. Immunol. 156:4859.
46. Yokoyama, A., N. Kohno, S. Fujino, H. Hamada, Y. Inoue, S. Fujioka, S. Ishida, and K. Hiwada. 1995. Circulating interleukin-6 levels in patients with bronchial asthma. Am. J. Respir. Crit. Care Med. 151:1354.
47. Tillie-Leblond, I., P. Gosset, A. Janin, F. Salez, L. Prin, and A. B. Tonnel. 1998. Increased interleukin-6 production during the acute phase of the syndrome of episodic angioedema and hypereosinophilia. Clin. Exp. Allergy 28:491.
48. Hatano, Y., K. Katagiri, and S. Takayasu. 1999. Heterogeneity in expression of cytokine mRNA in freshly isolated peripheral blood eosinophils of patients with cutaneous-disease-associated eosinophilia. Int. Arch. Allergy Immunol. 120(Suppl. 1):86.
49. Adachi, T., B. K. Choudhury, S. Stafford, S. Sur, and R. Alam. 2000. The differential role of extracellular signal-regulated kinases and p38 mitogen-activated protein kinase in eosinophil functions. J. Immunol. 165:2198.
50. Hartnell, A., D. S. Robinson, A. B. Kay, and A. J. Wardlaw. 1993. CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines. Immunology 80:281.
51. Haynes, B. F., L. P. Hale, K. L. Patton, M. E. Martin, and R. M. McCallum. 1991. Measurement of an adhesion molecule as an indicator of inflammatory disease activity: up-regulation of the receptor for hyaluronate (CD44) in rheumatoid arthritis. Arthritis Rheum. 34:1434.
52. Huang, M. C., M. Graeler, G. Shankar, J. Spencer, and E. J. Goetzl. 2002. Lysophospholipid mediators of immunity and neoplasia. Biochim. Biophys. Acta 1582:161.
53. Lee, E., T. Robertson, J. Smith, and S. Kilfeather. 2000. Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals. Am. J. Respir. Crit. Care Med. 161:1881.
54. Bandeira-Melo, C., J. C. Hall, J. F. Penrose, and P. F. Weller. 2002. Cysteinyl leukotrienes induce IL-4 release from cord blood-derived human eosinophils. J. Allergy Clin. Immunol. 109:975.
55. 2 associated with cell surfaces via C-terminal heparin-binding lysine residues augments stimulus-initiated delayed prostaglandin generation. J. Biol. Chem. 271:30041.
56. 28 in human embryonic kidney 293 and rat mastocytoma RBL-2H3 cells through heparan sulfate shuttling and external plasma membrane mechanisms. J. Biol. Chem. 276:10083.
57. 2 internalization and degradation. J. Biol. Chem. 276:11126.
58. 2 by heparin. Eur. J. Biochem. 221:481.
59. 2. Trends Pharmacol. Sci. 20:162.
60. 2 on isolated porcine cerebral arteries via its specific binding sites. FEBS Lett. 309:261.